1 active not recruiting, 1 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Sample Collection: new trials by email Literature Review of Sample Collection trials Research Report on Sample Collection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease Biospecimen Collection, Dasatinib, Fisetin - Glioma | Early Phase 1 | Recruiting | Mayo Clinic | 30 | 2025-08-12 | 2026-10-01 |
| Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy Biopsy Procedure, Biospecimen Collection, Resection - Endometrial Serous Adenocarcinoma | Early Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 12 | 2022-02-08 | 2026-11-18 |
Glioma (1)
Mayo Clinic (1) · National Cancer Institute (NCI) (1)
United States (2)
Rebecca L Stone (1) · Terence C. Burns, MD, PhD (1)
UM1CA186691 (1)